The company will use the funds to increase research and development efforts to make robotics surgery more accessible.

Photo: Dana Neely/Getty Images
Cornerstone Robotics (CSR), a surgical robotics company, announced it raised more than $70 million in Series C funding.
EQT led the round, with participation from Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology Venture Fund, eGarden Ventures, CTS Funds, K2VC, and Long-Z Capital.
WHAT IT DOES
CSR manufactures advanced surgical systems. In 2024, the company obtained the National Medical Products Administration (NMPA) approval in China for "Sentire," its Endoscopic Surgical System.
The company will use the funds to hasten its efforts in advancing the commercialization process, develop new surgical robotics products, conduct clinical trials, obtain regulatory approvals and promote global adoption of advanced robotic surgical solutions.
"Cornerstone Robotics experienced several pivotal milestones over the past year. We are deeply grateful to our shareholders for their trust and support," Samuel Au, founder and CEO of Cornerstone Robotics, said in a statement.
"This milestone is not only a recognition of our team's efforts in translating surgical robotics innovations into practical applications but also a testament to our commitment to long-term, high-quality development."
MARKET SNAPSHOT
Other companies in the surgical robotics space include Agilis Robotics, which specializes in the development of robotic instruments for endoluminal surgery within the medical technology sector.
Agilis offers miniaturized robotic systems designed to integrate with clinical workflows and improve the efficacy of endoscopic surgery, particularly for early-stage gastrointestinal and urinary tract cancers.
In 2024, Agilis Robotics announced the successful completion of a robot-assisted en-bloc resection of a bladder tumor using a self-developed, fully flexible endoscopic surgical robotic system.
SS Innovations develops advanced surgical robotic systems. The company offers a range of products including robotic systems for surgery, endosurgical instruments, and mixed reality training platforms for surgeons. It recently performed two robotic cardiac tele-surgeries in just two days.
DocRobo researches and develops medical robotic products and solutions. It focuses on formulating parallel surgical robotic devices, flexible robotic arms, machine vision technology and automatic surgery.